X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs MERCK LTD - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD MERCK LTD ORCHID PHARMA LTD/
MERCK LTD
 
P/E (TTM) x -0.8 26.1 - View Chart
P/BV x 0.6 2.9 19.1% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 ORCHID PHARMA LTD   MERCK LTD
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
MERCK LTD
Dec-16
ORCHID PHARMA LTD/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1941,060 18.3%   
Low Rs35623 5.6%   
Sales per share (Unadj.) Rs276.5632.4 43.7%  
Earnings per share (Unadj.) Rs-79.245.7 -173.3%  
Cash flow per share (Unadj.) Rs-43.562.3 -69.7%  
Dividends per share (Unadj.) Rs011.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs53.9388.8 13.9%  
Shares outstanding (eoy) m70.4516.60 424.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.3 31.1%   
Avg P/E ratio x-1.418.4 -7.9%  
P/CF ratio (eoy) x-2.613.5 -19.5%  
Price / Book Value ratio x2.12.2 98.1%  
Dividend payout %024.1 0.0%   
Avg Mkt Cap Rs m8,06713,969 57.7%   
No. of employees `0002.81.6 176.9%   
Total wages/salary Rs m2,5271,487 170.0%   
Avg. sales/employee Rs Th6,956.16,631.9 104.9%   
Avg. wages/employee Rs Th902.5939.2 96.1%   
Avg. net profit/employee Rs Th-1,993.0479.4 -415.7%   
INCOME DATA
Net Sales Rs m19,47710,498 185.5%  
Other income Rs m407242 168.0%   
Total revenues Rs m19,88410,741 185.1%   
Gross profit Rs m1,1031,135 97.1%  
Depreciation Rs m2,519276 914.4%   
Interest Rs m5,2270-   
Profit before tax Rs m-6,2361,102 -565.8%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125343 -36.5%   
Profit after tax Rs m-5,580759 -735.3%  
Gross profit margin %5.710.8 52.3%  
Effective tax rate %2.031.1 6.4%   
Net profit margin %-28.77.2 -396.3%  
BALANCE SHEET DATA
Current assets Rs m11,0146,410 171.8%   
Current liabilities Rs m32,0608,828 363.2%   
Net working cap to sales %-108.1-23.0 469.0%  
Current ratio x0.30.7 47.3%  
Inventory Days Days9558 164.5%  
Debtors Days Days3438 87.4%  
Net fixed assets Rs m29,4401,406 2,093.3%   
Share capital Rs m705166 424.4%   
"Free" reserves Rs m2,0436,286 32.5%   
Net worth Rs m3,8006,455 58.9%   
Long term debt Rs m9,0180-   
Total assets Rs m46,5108,828 526.8%  
Interest coverage x-0.2NM-  
Debt to equity ratio x2.40-  
Sales to assets ratio x0.41.2 35.2%   
Return on assets %-0.88.6 -8.8%  
Return on equity %-146.911.8 -1,249.0%  
Return on capital %-3.717.1 -21.9%  
Exports to sales %37.98.3 457.4%   
Imports to sales %22.621.0 107.5%   
Exports (fob) Rs m7,378869 848.6%   
Imports (cif) Rs m4,4062,209 199.4%   
Fx inflow Rs m7,513959 783.6%   
Fx outflow Rs m5,6492,612 216.3%   
Net fx Rs m1,865-1,653 -112.8%   
CASH FLOW
From Operations Rs m1,6821,070 157.1%  
From Investments Rs m-9,860-750 1,315.2%  
From Financial Activity Rs m6,644-150 -4,435.1%  
Net Cashflow Rs m-1,535171 -898.2%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 4.6 18.2 25.3%  
FIIs % 3.3 1.0 330.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 29.1 190.0%  
Shareholders   84,811 28,591 296.6%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   GLENMARK PHARMA  FULFORD INDIA  WYETH LTD  AJANTA PHARMA  UNICHEM LAB  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS